REFERENCES
1. Liu, R., et al., Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data. medRxiv, 2020.
2. Sahin, A.R., et al., 2019 novel coronavirus (COVID-19) outbreak: a review of the current literature. EJMO, 2020.4 (1): p. 1-7.
3. Organization, W.H., Coronavirus disease 2019 (COVID-19): situation report, 67. 2020.
4. Bikdeli, B., et al., COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. Journal of the American College of Cardiology, 2020.
5. Thachil, J., et al., ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. Journal of Thrombosis and Haemostasis, 2020. 18 (5): p. 1023-1026.
6. Poissy, J., et al., Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence. Circulation, 2020.
7. Oxley, T.J., et al., Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. New England Journal of Medicine, 2020: p. e60.
8. Li, Y., et al., Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. 2020.
9. Branchford, B.R. and S.L. Carpenter, The role of inflammation in venous thromboembolism. Frontiers in pediatrics, 2018. 6 : p. 142.